Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug:156:80-84.
doi: 10.1016/j.antiviral.2018.06.009. Epub 2018 Jun 14.

Prediction and prevention of urban arbovirus epidemics: A challenge for the global virology community

Affiliations
Review

Prediction and prevention of urban arbovirus epidemics: A challenge for the global virology community

Scott C Weaver. Antiviral Res. 2018 Aug.

Abstract

The recent emergence and rapid spread of Zika virus in tropical regions of the Western Hemisphere took arbovirologists and public health officials by surprise, and the earlier transfers of West Nile and chikungunya viruses from the Old to the New World were also unexpected. These pandemics underscore the increasing threat of zoonotic arboviruses, especially those that are capable of entering into human-amplified, urban transmission cycles transmitted by Aedes (Stegomyia) aegypti and sometimes other Aedes (Stegomyia) spp. mosquitoes. This review serves as an introduction to a World Health Organization-sponsored conference to be held on June 18-19, 2018 in Geneva, titled "From obscurity to urban epidemics: what are the next urban arboviruses?" It is intended to set the stage and fuel discussions of future urban arbovirus threats, how we can predict these risks from known and unknown viruses, and what factors may change these risks over time.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest:

Scott Weaver holds patents for alphavirus vaccine development, including chikungunya.

Figures

Fig. 1.
Fig. 1.
The most common mechanism of human infection by most arboviruses is direct spillover from enzootic transmission cycles (involving various wildlife as amplification hosts). This occurs when enzootic vectors, or bridge vectors that bite both wild animals and humans, transmit. An example is West Nile virus, which emerged in the Americas after its introduction into New York in 1999, and which uses birds as amplification hosts and Culex spp. mosquitoes as vectors (Roehrig, 2013).
Fig. 2.
Fig. 2.
Some arboviruses undergo secondary amplification in domesticated animals with spillover to humans, resulting in increased exposure and disease. Examples include epizootic strains of Venezuelan equine encephalitis virus, which amplify in equids as during the last major epizootic/epidemic in Venezuela and Colombia in 1995 (Weaver et al., 1996); another is Japanese encephalitis virus, which amplifies in swine and causes endemic disease in the Asian topics and summer epidemics in temperate climates (Pearce et al., 2018); and another is Rift Valley fever virus, which amplifies in ruminants, with several epizootics/epidemics since 2000 (Kenawy et al., 2018).
Fig. 3.
Fig. 3.
The most important human arboviral pathogens undergo human-amplified, typically urban transmission cycles, which evolve from primate-amplified, ancestral enzootic cycles (see Fig. 1). These include dengue, yellow fever, chikungunya and Zika viruses (Wilder-Smith et al., 2016). Direct human-human transmission (arrow at top) has only been documented for Zika virus (Aliota et al., 2017).

References

    1. Aguilar PV, Estrada-Franco JG, Navarro-Lopez R, Ferro C, Haddow AD, Weaver SC, 2011. Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella. Future Virol 6, 721–740. - PMC - PubMed
    1. Aliota MT, Bassit L, Bradrick SS, Cox B, Garcia-Blanco MA, Gavegnano C, Friedrich TC, Golos TG, Griffin DE, Haddow AD, Kallas EG, Kitron U, Lecuit M, Magnani DM, Marrs C, Mercer N, McSweegan E, Ng LFP, O’Connor DH, Osorio JE, Ribeiro GS, Ricciardi M, Rossi SL, Saade G, Schinazi RF, Schott-Lerner GO, Shan C, Shi PY, Watkins DI, Vasilakis N, Weaver SC, 2017. Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network. Antiviral Res 144, 223–246. - PMC - PubMed
    1. Barzon L, Pacenti M, Ulbert S, Palu G, 2015. Latest developments and challenges in the diagnosis of human West Nile virus infection. Expert Rev Anti Infect Ther 13, 327–342. - PubMed
    1. Beasley DW, McAuley AJ, Bente DA, 2015. Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy. Antiviral Res 115, 48–70. - PubMed
    1. Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M, 2014. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill 19. - PubMed

Publication types